VJHemOnc is committed to improving our service to you

ASCO 2019 | Lymphoma: predicting response

VJHemOnc is committed to improving our service to you

Frederick Locke

Frederick Locke, MD, of the Moffitt Cancer Center, Tampa, FL, discusses the methods that can be used to predict durable response in lymphoma patients being treated with CAR T-cell therapy. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter